These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38993804)

  • 1. Design and Realization of Lung Organoid Cultures for COVID-19 Applications.
    Ren B; Chiaravalloti TR; Belony NL; Romero DI; Chai W; Leon C; Wu L; Lamango NS; Offringa IA; Huang Y
    Biodes Manuf; 2023 Nov; 6(6):646-660. PubMed ID: 38993804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models.
    Basu A; Pamreddy A; Singh P; Sharma K
    J Mol Biol; 2022 Feb; 434(3):167213. PubMed ID: 34437890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human organoid models to study SARS-CoV-2 infection.
    Han Y; Yang L; Lacko LA; Chen S
    Nat Methods; 2022 Apr; 19(4):418-428. PubMed ID: 35396481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.
    Wang Y; Wang P; Qin J
    Adv Sci (Weinh); 2022 Apr; 9(10):e2105187. PubMed ID: 35107217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
    Egilmezer E; Rawlinson WD
    Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid and microfluidics-based platforms for drug screening in COVID-19.
    Ramezankhani R; Solhi R; Chai YC; Vosough M; Verfaillie C
    Drug Discov Today; 2022 Apr; 27(4):1062-1076. PubMed ID: 34954328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
    Dawoody Nejad L; Julian LM
    Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.
    Kronemberger GS; Carneiro FA; Rezende DF; Baptista LS
    Artif Organs; 2021 Jun; 45(6):548-558. PubMed ID: 33264436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Human Induced Pluripotent Stem Cell-Derived Cellular and Organoid Models for COVID-19 Research.
    Luo Y; Zhang M; Chen Y; Chen Y; Zhu D
    Front Cell Dev Biol; 2021; 9():720099. PubMed ID: 34552930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defense of COVID-19 by Human Organoids.
    Lv T; Meng F; Yu M; Huang H; Lin X; Zhao B
    Phenomics; 2021; 1(3):113-128. PubMed ID: 35233559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19.
    da Silva da Costa FA; Soares MR; Malagutti-Ferreira MJ; da Silva GR; Lívero FADR; Ribeiro-Paes JT
    Tissue Eng Regen Med; 2021 Oct; 18(5):735-745. PubMed ID: 34080133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities.
    Chen J; Na F
    Front Bioeng Biotechnol; 2022; 10():1066869. PubMed ID: 36568297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.
    Ye C; Qi L; Wang J; Zheng S
    Front Med (Lausanne); 2021; 8():606755. PubMed ID: 33855032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in organoid engineering: A comprehensive review.
    Unagolla JM; Jayasuriya AC
    Appl Mater Today; 2022 Dec; 29():. PubMed ID: 38264423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection.
    Ni K; Che B; Yang C; Qin Y; Gu R; Wang C; Luo M; Deng L
    Front Pharmacol; 2022; 13():1033043. PubMed ID: 36578545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoid Technologies for SARS-CoV-2 Research.
    Sutton K; Leach T; Surendran V; Clapp P; Murphy S
    Curr Stem Cell Rep; 2022; 8(4):151-163. PubMed ID: 36313938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.
    Satta S; Shahabipour F; Gao W; Lentz SR; Perlman S; Ashammakhi N; Hsiai T
    Theranostics; 2022; 12(10):4779-4790. PubMed ID: 35832078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological features of SARS-CoV-2 infection and relationships with organoid technology.
    İnanç İ; Erdemli E
    J Int Med Res; 2021 Sep; 49(9):3000605211044382. PubMed ID: 34521239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.